CONDENSED CONSOLIDATING FINANCIAL INFORMATION | CONDENSED CONSOLIDATING FINANCIAL INFORMATION: The following information sets forth the condensed consolidating balance sheets as of November 30, 2015 , and February 28, 2015 , the condensed consolidating statements of comprehensive income for the nine months and three months ended November 30, 2015 , and November 30, 2014 , and the condensed consolidating statements of cash flows for the nine months ended November 30, 2015 , and November 30, 2014 , for the parent company, our combined subsidiaries which guarantee our senior notes (“Subsidiary Guarantors”), our combined subsidiaries which are not Subsidiary Guarantors (primarily foreign subsidiaries) (“Subsidiary Nonguarantors”) and the Company. The Subsidiary Guarantors are 100% owned, directly or indirectly, by the parent company and the guarantees are joint and several obligations of each of the Subsidiary Guarantors. The guarantees are full and unconditional, as those terms are used in Rule 3-10 of Regulation S-X, except that a Subsidiary Guarantor can be automatically released and relieved of its obligations under certain customary circumstances contained in the indentures governing our senior notes. These customary circumstances include, so long as other applicable provisions of the indentures are adhered to, the termination or release of a Subsidiary Guarantor’s guarantee of other indebtedness or upon the legal defeasance or covenant defeasance or satisfaction and discharge of our senior notes. Separate financial statements for our Subsidiary Guarantors are not presented because we have determined that such financial statements would not be material to investors. The accounting policies of the parent company, the Subsidiary Guarantors and the Subsidiary Nonguarantors are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2015 Annual Report. There are no restrictions on the ability of the Subsidiary Guarantors to transfer funds to us in the form of cash dividends, loans or advances. Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Balance Sheet at November 30, 2015 Current assets: Cash and cash equivalents $ 260.5 $ 0.9 $ 229.9 $ — $ 491.3 Accounts receivable — 5.0 709.7 — 714.7 Inventories 160.9 1,464.9 348.5 (89.7 ) 1,884.6 Intercompany receivable 16,322.2 22,233.7 8,488.0 (47,043.9 ) — Prepaid expenses and other 43.6 46.9 325.3 (45.5 ) 370.3 Total current assets 16,787.2 23,751.4 10,101.4 (47,179.1 ) 3,460.9 Property, plant and equipment 56.6 829.3 2,063.1 — 2,949.0 Investments in subsidiaries 12,626.2 17.9 — (12,644.1 ) — Goodwill — 5,614.5 767.3 — 6,381.8 Intangible assets — 747.7 2,438.2 1.9 3,187.8 Intercompany notes receivable 3,922.5 86.6 — (4,009.1 ) — Other assets 57.7 88.0 31.4 — 177.1 Total assets $ 33,450.2 $ 31,135.4 $ 15,401.4 $ (63,830.4 ) $ 16,156.6 Current liabilities: Notes payable to banks $ — $ — $ 31.1 $ — $ 31.1 Current maturities of long-term debt 765.3 18.5 73.1 — 856.9 Accounts payable 32.3 239.0 149.6 — 420.9 Accrued excise taxes 17.8 9.7 5.0 — 32.5 Intercompany payable 20,752.2 17,548.5 8,743.2 (47,043.9 ) — Other accrued expenses and liabilities 257.2 197.8 195.9 (71.5 ) 579.4 Total current liabilities 21,824.8 18,013.5 9,197.9 (47,115.4 ) 1,920.8 Long-term debt, less current maturities 5,081.0 29.1 1,404.9 — 6,515.0 Deferred income taxes 28.4 692.3 265.7 — 986.4 Intercompany notes payable — 3,993.2 15.9 (4,009.1 ) — Other liabilities 23.6 34.9 79.2 — 137.7 Total liabilities 26,957.8 22,763.0 10,963.6 (51,124.5 ) 9,559.9 Total CBI stockholders’ equity 6,492.4 8,372.4 4,333.5 (12,705.9 ) 6,492.4 Noncontrolling interests — — 104.3 — 104.3 Total stockholders’ equity 6,492.4 8,372.4 4,437.8 (12,705.9 ) 6,596.7 Total liabilities and stockholders’ equity $ 33,450.2 $ 31,135.4 $ 15,401.4 $ (63,830.4 ) $ 16,156.6 Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Balance Sheet at February 28, 2015 Current assets: Cash and cash equivalents $ 24.5 $ 0.7 $ 84.9 $ — $ 110.1 Accounts receivable 0.8 27.3 570.8 — 598.9 Inventories 153.3 1,419.0 357.7 (102.8 ) 1,827.2 Intercompany receivable 13,158.7 18,389.9 6,512.0 (38,060.6 ) — Prepaid expenses and other 46.2 94.0 427.0 (192.6 ) 374.6 Total current assets 13,383.5 19,930.9 7,952.4 (38,356.0 ) 2,910.8 Property, plant and equipment 59.3 854.5 1,767.8 — 2,681.6 Investments in subsidiaries 11,657.2 13.8 — (11,671.0 ) — Goodwill — 5,411.3 796.9 — 6,208.2 Intangible assets — 703.3 2,474.3 3.4 3,181.0 Intercompany notes receivable 4,087.3 129.9 — (4,217.2 ) — Other assets 61.4 68.4 33.1 — 162.9 Total assets $ 29,248.7 $ 27,112.1 $ 13,024.5 $ (54,240.8 ) $ 15,144.5 Current liabilities: Notes payable to banks $ — $ — $ 52.4 $ — $ 52.4 Current maturities of long-term debt 92.3 16.9 48.9 — 158.1 Accounts payable 41.2 113.2 131.4 — 285.8 Accrued excise taxes 12.6 11.3 4.8 — 28.7 Intercompany payable 17,206.7 14,201.6 6,652.3 (38,060.6 ) — Other accrued expenses and liabilities 462.5 211.2 156.9 (224.9 ) 605.7 Total current liabilities 17,815.3 14,554.2 7,046.7 (38,285.5 ) 1,130.7 Long-term debt, less current maturities 5,601.4 30.9 1,505.2 — 7,137.5 Deferred income taxes 17.6 633.6 167.7 — 818.9 Intercompany notes payable — 3,863.4 353.8 (4,217.2 ) — Other liabilities 43.7 36.7 95.7 — 176.1 Total liabilities 23,478.0 19,118.8 9,169.1 (42,502.7 ) 9,263.2 Total CBI stockholders’ equity 5,770.7 7,993.3 3,744.8 (11,738.1 ) 5,770.7 Noncontrolling interests — — 110.6 — 110.6 Total stockholders’ equity 5,770.7 7,993.3 3,855.4 (11,738.1 ) 5,881.3 Total liabilities and stockholders’ equity $ 29,248.7 $ 27,112.1 $ 13,024.5 $ (54,240.8 ) $ 15,144.5 Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Statement of Comprehensive Income for the Nine Months Ended November 30, 2015 Sales $ 1,891.7 $ 4,289.2 $ 2,294.4 $ (2,952.0 ) $ 5,523.3 Less – excise taxes (251.3 ) (219.4 ) (47.4 ) — (518.1 ) Net sales 1,640.4 4,069.8 2,247.0 (2,952.0 ) 5,005.2 Cost of product sold (1,325.4 ) (3,023.4 ) (1,377.4 ) 2,967.2 (2,759.0 ) Gross profit 315.0 1,046.4 869.6 15.2 2,246.2 Selling, general and administrative expenses (281.5 ) (508.9 ) (96.8 ) (5.0 ) (892.2 ) Operating income 33.5 537.5 772.8 10.2 1,354.0 Equity in earnings of equity method investees and subsidiaries 924.9 31.8 0.8 (929.0 ) 28.5 Interest income 0.1 — 0.4 — 0.5 Intercompany interest income 138.0 196.6 0.1 (334.7 ) — Interest expense (212.3 ) (0.9 ) (17.7 ) — (230.9 ) Intercompany interest expense (196.2 ) (137.9 ) (0.6 ) 334.7 — Loss on write-off of financing costs (0.4 ) — (0.7 ) — (1.1 ) Income before income taxes 687.6 627.1 755.1 (918.8 ) 1,151.0 (Provision for) benefit from income taxes 123.9 (247.1 ) (208.2 ) (4.3 ) (335.7 ) Net income 811.5 380.0 546.9 (923.1 ) 815.3 Net income attributable to noncontrolling interests — — (3.8 ) — (3.8 ) Net income attributable to CBI $ 811.5 $ 380.0 $ 543.1 $ (923.1 ) $ 811.5 Comprehensive income attributable to CBI $ 597.5 $ 379.1 $ 325.6 $ (704.7 ) $ 597.5 Condensed Consolidating Statement of Comprehensive Income for the Nine Months Ended November 30, 2014 Sales $ 1,802.0 $ 3,927.3 $ 2,300.8 $ (2,864.4 ) $ 5,165.7 Less – excise taxes (241.9 ) (204.3 ) (47.7 ) — (493.9 ) Net sales 1,560.1 3,723.0 2,253.1 (2,864.4 ) 4,671.8 Cost of product sold (1,259.0 ) (2,849.7 ) (1,423.8 ) 2,841.7 (2,690.8 ) Gross profit 301.1 873.3 829.3 (22.7 ) 1,981.0 Selling, general and administrative expenses (291.2 ) (410.4 ) (145.1 ) 12.2 (834.5 ) Operating income 9.9 462.9 684.2 (10.5 ) 1,146.5 Equity in earnings of equity method investees and subsidiaries 761.3 23.5 1.0 (764.7 ) 21.1 Interest income — — 1.0 — 1.0 Intercompany interest income 133.2 162.5 0.2 (295.9 ) — Interest expense (224.4 ) (1.0 ) (33.0 ) — (258.4 ) Intercompany interest expense (162.1 ) (133.0 ) (0.8 ) 295.9 — Loss on write-off of financing costs — — (4.4 ) — (4.4 ) Income before income taxes 517.9 514.9 648.2 (775.2 ) 905.8 (Provision for) benefit from income taxes 106.8 (192.0 ) (198.9 ) 3.0 (281.1 ) Net income 624.7 322.9 449.3 (772.2 ) 624.7 Net income attributable to noncontrolling interests — — — — — Net income attributable to CBI $ 624.7 $ 322.9 $ 449.3 $ (772.2 ) $ 624.7 Comprehensive income attributable to CBI $ 530.1 $ 324.7 $ 350.9 $ (675.6 ) $ 530.1 Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Statement of Comprehensive Income for the Three Months Ended November 30, 2015 Sales $ 708.1 $ 1,366.8 $ 676.4 $ (938.9 ) $ 1,812.4 Less – excise taxes (91.6 ) (64.6 ) (15.7 ) — (171.9 ) Net sales 616.5 1,302.2 660.7 (938.9 ) 1,640.5 Cost of product sold (496.9 ) (943.8 ) (425.3 ) 959.0 (907.0 ) Gross profit 119.6 358.4 235.4 20.1 733.5 Selling, general and administrative expenses (81.9 ) (157.6 ) (34.6 ) (12.1 ) (286.2 ) Operating income 37.7 200.8 200.8 8.0 447.3 Equity in earnings of equity method investees and subsidiaries 298.6 28.1 0.4 (299.8 ) 27.3 Interest income — — 0.1 — 0.1 Intercompany interest income 46.0 66.3 0.1 (112.4 ) — Interest expense (71.5 ) (0.3 ) (3.9 ) — (75.7 ) Intercompany interest expense (66.2 ) (46.0 ) (0.2 ) 112.4 — Income before income taxes 244.6 248.9 197.3 (291.8 ) 399.0 (Provision for) benefit from income taxes 25.9 (99.2 ) (51.4 ) (3.3 ) (128.0 ) Net income 270.5 149.7 145.9 (295.1 ) 271.0 Net income attributable to noncontrolling interests — — (0.5 ) — (0.5 ) Net income attributable to CBI $ 270.5 $ 149.7 $ 145.4 $ (295.1 ) $ 270.5 Comprehensive income attributable to CBI $ 295.8 $ 149.0 $ 169.8 $ (318.8 ) $ 295.8 Condensed Consolidating Statement of Comprehensive Income for the Three Months Ended November 30, 2014 Sales $ 662.8 $ 1,267.8 $ 695.4 $ (917.4 ) $ 1,708.6 Less – excise taxes (88.7 ) (65.2 ) (13.0 ) — (166.9 ) Net sales 574.1 1,202.6 682.4 (917.4 ) 1,541.7 Cost of product sold (462.1 ) (943.3 ) (410.9 ) 913.5 (902.8 ) Gross profit 112.0 259.3 271.5 (3.9 ) 638.9 Selling, general and administrative expenses (97.1 ) (109.4 ) (61.6 ) 4.8 (263.3 ) Operating income 14.9 149.9 209.9 0.9 375.6 Equity in earnings of equity method investees and subsidiaries 252.3 21.7 0.4 (253.2 ) 21.2 Interest income — — 0.4 — 0.4 Intercompany interest income 44.7 58.7 — (103.4 ) — Interest expense (78.4 ) (0.3 ) (7.7 ) — (86.4 ) Intercompany interest expense (58.6 ) (44.6 ) (0.2 ) 103.4 — Income before income taxes 174.9 185.4 202.8 (252.3 ) 310.8 (Provision for) benefit from income taxes 47.3 (68.9 ) (66.5 ) (0.5 ) (88.6 ) Net income 222.2 116.5 136.3 (252.8 ) 222.2 Net income attributable to noncontrolling interests — — — — — Net income attributable to CBI $ 222.2 $ 116.5 $ 136.3 $ (252.8 ) $ 222.2 Comprehensive income attributable to CBI $ 108.8 $ 117.2 $ 21.5 $ (138.7 ) $ 108.8 Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Statement of Cash Flows for the Nine Months Ended November 30, 2015 Net cash provided by (used in) operating activities $ (456.3 ) $ 775.1 $ 772.8 $ — $ 1,091.6 Cash flows from investing activities: Purchases of property, plant and equipment (8.8 ) (31.8 ) (473.2 ) — (513.8 ) Purchase of business — (316.2 ) (1.7 ) — (317.9 ) Net proceeds from intercompany notes 376.4 — — (376.4 ) — Net investments in equity affiliates (236.4 ) — — 236.4 — Other investing activities 2.0 (0.7 ) 2.7 — 4.0 Net cash provided by (used in) investing activities 133.2 (348.7 ) (472.2 ) (140.0 ) (827.7 ) Cash flows from financing activities: Net contributions from (returns of capital to) equity affiliates — (31.4 ) 267.8 (236.4 ) — Net proceeds from (repayments of) intercompany notes 292.2 (345.3 ) (323.3 ) 376.4 — Proceeds from issuance of long-term debt 200.0 — 10.0 — 210.0 Excess tax benefits from stock-based payment awards 204.2 — — — 204.2 Proceeds from shares issued under equity compensation plans 98.9 — — — 98.9 Dividends paid (180.4 ) — — — (180.4 ) Principal payments of long-term debt (47.9 ) (13.8 ) (86.6 ) — (148.3 ) Payments of minimum tax withholdings on stock-based payment awards — (35.7 ) (2.7 ) — (38.4 ) Net repayments of notes payable — — (15.9 ) — (15.9 ) Payments of financing costs of long-term debt (7.9 ) — — — (7.9 ) Net cash provided by (used in) financing activities 559.1 (426.2 ) (150.7 ) 140.0 122.2 Effect of exchange rate changes on cash and cash equivalents — — (4.9 ) — (4.9 ) Net increase in cash and cash equivalents 236.0 0.2 145.0 — 381.2 Cash and cash equivalents, beginning of period 24.5 0.7 84.9 — 110.1 Cash and cash equivalents, end of period $ 260.5 $ 0.9 $ 229.9 $ — $ 491.3 Parent Company Subsidiary Guarantors Subsidiary Nonguarantors Eliminations Consolidated (in millions) Condensed Consolidating Statement of Cash Flows for the Nine Months Ended November 30, 2014 Net cash provided by (used in) operating activities $ (395.1 ) $ 468.9 $ 676.3 $ — $ 750.1 Cash flows from investing activities: Purchases of property, plant and equipment (17.4 ) (70.3 ) (453.6 ) — (541.3 ) Purchase of business — — (21.4 ) — (21.4 ) Net proceeds from intercompany notes 70.9 — — (70.9 ) — Net investments in equity affiliates (28.8 ) — — 28.8 — Other investing activities — (5.6 ) 8.6 — 3.0 Net cash provided by (used in) investing activities 24.7 (75.9 ) (466.4 ) (42.1 ) (559.7 ) Cash flows from financing activities: Dividends paid to parent company — — (24.9 ) 24.9 — Net contributions from (returns of capital to) equity affiliates — (24.5 ) 78.2 (53.7 ) — Net proceeds from (repayments of) intercompany notes 26.3 (327.9 ) 230.7 70.9 — Proceeds from issuance of long-term debt 800.0 — — — 800.0 Excess tax benefits from stock-based payment awards 76.0 — — — 76.0 Proceeds from shares issued under equity compensation plans 34.2 — — — 34.2 Principal payments of long-term debt (533.0 ) (14.5 ) (17.8 ) — (565.3 ) Payments of minimum tax withholdings on stock-based payment awards — (26.1 ) (2.3 ) — (28.4 ) Net proceeds from notes payable — — 50.6 — 50.6 Payments of financing costs of long-term debt (11.2 ) — (2.1 ) — (13.3 ) Payment of delayed purchase price arrangement — — (543.3 ) — (543.3 ) Net cash provided by (used in) financing activities 392.3 (393.0 ) (230.9 ) 42.1 (189.5 ) Effect of exchange rate changes on cash and cash equivalents — — 2.5 — 2.5 Net increase (decrease) in cash and cash equivalents 21.9 — (18.5 ) — 3.4 Cash and cash equivalents, beginning of period 0.5 0.8 62.6 — 63.9 Cash and cash equivalents, end of period $ 22.4 $ 0.8 $ 44.1 $ — $ 67.3 |